United States v. Mejia

CourtCourt of Appeals for the First Circuit
DecidedDecember 2, 2022
Docket21-1815P
StatusPublished

This text of United States v. Mejia (United States v. Mejia) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Mejia, (1st Cir. 2022).

Opinion

United States Court of Appeals For the First Circuit

No. 21-1815

UNITED STATES OF AMERICA,

Appellee,

v.

JULIO MEJIA, a/k/a Carlos,

Defendant, Appellant.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MAINE

[Hon. D. Brock Hornby, U.S. District Judge]

Before

Barron, Chief Judge, Selya and Gelpí, Circuit Judges.

Thomas J. Gleason and Gleason Law Offices, P.C. on brief for appellant. Kenneth A. Polite, Jr., Assistant Attorney General, Criminal Division, United States Department of Justice, Lisa H. Miller, Deputy Assistant Attorney General, Criminal Division, W. Connor Winn, Criminal Division, Appellate Section, Darcie N. McElwee, United States Attorney, Benjamin M. Block, Chief, Appellate Division, Johnathan G. Nathans, Assistant United States Attorney, on brief for appellee. November 8, 2022 SELYA, Circuit Judge. In this case, the district court

allowed the government to rescind a plea agreement previously

entered into with defendant-appellant Julio Mejia and proceeded to

sentence the defendant to a 162-month term of immurement. The

defendant appeals, arguing that the court should not have allowed

the rescission of the plea agreement and that, compounding this

blunder, the court miscalculated drug quantity and incorrectly

imposed a role-in-the-offense enhancement. Concluding, as we do,

that the defendant is foraging in an empty cupboard, we affirm.

I

We briefly rehearse the relevant facts and travel of the

case. "Where, as here, a sentencing appeal follows a guilty plea,

we glean the relevant facts from the change-of-plea colloquy, the

unchallenged portions of the presentence investigation report (PSI

Report), and the record of the disposition hearing." United States

v. Vargas, 560 F.3d 45, 47 (1st Cir. 2009).

In 2016, the authorities began investigating a sprawling

drug-trafficking organization that was supplying significant

amounts of cocaine and fentanyl to drug dealers throughout Maine,

New Hampshire, and Massachusetts. The defendant was involved hip-

deep in the activities of the organization: at least until the

end of 2016, he received orders from customers, set drug prices,

and arranged the itineraries for drug couriers.

- 3 - In December of 2016, the defendant turned over his list

of customers to an associate, Inyemar Manuel Suazo, and departed

for the Dominican Republic. His departure left Suazo in charge.

But after the defendant returned to the United States on May 7,

2017, he both resumed contact with Suazo and resumed involvement

in the original drug-trafficking organization. By September,

though, the two men had gone their separate ways, and the defendant

began running his own drug-trafficking enterprise.

The defendant's new enterprise involved some persons who

had been participants in the original drug-trafficking

organization. This roster of past participants included a courier,

Rafael Espinal-Calderon. The defendant continued distributing

cocaine and fentanyl through this new network until his arrest in

2018.

In due course, a federal grand jury sitting in the

District of Maine charged the defendant with conspiracy to

distribute and to possess with intent to distribute 400 grams or

more of a mixture or substance containing fentanyl. See 21 U.S.C.

§§ 841(a)(1), 846. The defendant initially maintained his

innocence, but he later changed his plea, pursuant to a written

plea agreement. The district court accepted the defendant's guilty

plea and ordered the preparation of a PSI Report.

When received, the PSI Report recommended a criminal

history category of I and a total offense level (TOL) of forty-

- 4 - three. The TOL included a drug quantity attribution, see USSG

§2D1.1, a role-in-the-offense enhancement based on the defendant's

asserted leadership of "criminal activity that involved five or

more participants," id. §3B1.1(a), and a reduction for acceptance

of responsibility, see id. §3E1.1. The guideline recommendations

limned in the PSI Report yielded a guideline sentencing range of

life imprisonment.

In March of 2019, the defendant entered into a

cooperation agreement with the government, which both merged into

and supplemented his plea agreement. (For ease in exposition, we

henceforth refer to the plea agreement and the cooperation

agreement, collectively, as the "supplemented plea agreement.")

Pursuant to the supplemented plea agreement, the defendant pledged

to assist the government's ongoing investigation into drug-

trafficking activities in various ways (including testifying when

requested). For its part, the government pledged not to use any

of the information provided by the defendant against him, to make

his cooperation known upon his request, and to recommend a three-

level reduction for acceptance of responsibility under USSG

§3E1.1.

The defendant began cooperating with the government and

continued his assistance until November 27, 2020. At some time

prior to that date, Suazo apparently approached the defendant,

showed him a copy of the cooperation agreement, and threatened to

- 5 - post it online if the defendant testified. Fearing for his and

his family's safety, the defendant subsequently refused to testify

against Suazo.

The government responded to this development by

announcing that it would treat the supplemented plea agreement as

a nullity. The defendant tried to parry this thrust: he moved

either to scrap the indictment or to enforce the supplemented plea

agreement because the government had breached the latter by

withdrawing it "in bad faith." After determining that the

defendant's failure to testify against Suazo constituted a

material breach of the terms of the supplemented plea agreement,

the court denied the motion.

On September 27, 2021, the district court convened the

disposition hearing in the defendant's case. The government

reminded the court that the supplemented plea agreement had been

abrogated by the defendant's refusal to testify and, therefore,

should be deemed withdrawn. The defendant did not

contemporaneously object to the rescission of the supplemented

plea agreement, but his counsel urged the court to acknowledge the

defendant's cooperation when weighing the sentencing factors made

pertinent under 18 U.S.C. § 3553(a). Consequently, the

supplemented plea agreement was rejected by the court.

The disposition hearing devolved principally into an

exchange of views about the appropriateness vel non of the drug-

- 6 - quantity and role-in-the-offense recommendations contained in the

PSI Report. Amidst the sparring, the government suggested a 240-

month term of immurement, and the defendant suggested half that

time.

Regarding drug quantity, the district court concluded

that the PSI Report's figure (114,362.6618 kilograms of converted

drug weight)1 was "supportable based upon the testimony of runners

like Espinal-Calderon and others." And with respect to the four-

level role-in-the-offense enhancement, the court found that the

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Cintrón-Echautegui
604 F.3d 1 (First Circuit, 2010)
United States v. Clark
55 F.3d 9 (First Circuit, 1995)
United States v. Graciani
61 F.3d 70 (First Circuit, 1995)
United States v. Alegria
192 F.3d 179 (First Circuit, 1999)
United States v. Piper
298 F.3d 47 (First Circuit, 2002)
United States v. Santos
357 F.3d 136 (First Circuit, 2004)
Teragram Corporation v. MarketWatch.com,Inc.
444 F.3d 1 (First Circuit, 2006)
United States v. Vargas
560 F.3d 45 (First Circuit, 2009)
United States v. Juventino Carrillo
709 F.2d 35 (Ninth Circuit, 1983)
United States v. John F. Dunn, Jr.
758 F.2d 30 (First Circuit, 1985)
United States v. Aloyisius Juodakis
834 F.2d 1099 (First Circuit, 1987)
United States v. Ilario M.A. Zannino
895 F.2d 1 (First Circuit, 1990)
United States v. Bernier
660 F.3d 543 (First Circuit, 2011)
United States v. John Doe
233 F.3d 642 (First Circuit, 2000)
United States v. Rafael Ventura
353 F.3d 84 (First Circuit, 2003)
United States v. Flores-Machicote
706 F.3d 16 (First Circuit, 2013)
United States v. Almonte-Nunez
771 F.3d 84 (First Circuit, 2014)
United States v. Lilly
810 F.3d 1205 (Tenth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Mejia, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-mejia-ca1-2022.